valdecoxib has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Aty, AM; Cho, W; Hacimuftuoglu, A; Jeong, JH; Jung, TW; Park, SY | 1 |
1 other study(ies) available for valdecoxib and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Endoplasmic Reticulum Stress; Hepatocytes; Isoxazoles; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitates; RNA, Small Interfering; Sirtuins; Sulfonamides | 2022 |